BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17554348)

  • 1. Very early alloantigen-independent trafficking of lymphocytes during ischemic acute kidney injury.
    Gandolfo MT; Rabb H
    Kidney Int; 2007 Jun; 71(12):1193-5. PubMed ID: 17554348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.
    Awad AS; Ye H; Huang L; Li L; Foss FW; Macdonald TL; Lynch KR; Okusa MD
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1516-24. PubMed ID: 16403835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury.
    Lai LW; Yong KC; Igarashi S; Lien YH
    Kidney Int; 2007 Jun; 71(12):1223-31. PubMed ID: 17377506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury.
    Bajwa A; Huang L; Ye H; Dondeti K; Song S; Rosin DL; Lynch KR; Lobo PI; Li L; Okusa MD
    J Immunol; 2012 Sep; 189(5):2584-96. PubMed ID: 22855711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction of sphingosine-1-phosphate G protein-coupled receptors.
    Young N; Van Brocklyn JR
    ScientificWorldJournal; 2006 Aug; 6():946-66. PubMed ID: 16906327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sphingosine 1-phosphate receptors: from biology to physiopathology].
    Cuvillier O
    Med Sci (Paris); 2012 Nov; 28(11):951-7. PubMed ID: 23171898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reining in FoxP3(+) regulatory T cells by the sphingosine 1-phosphate-S1P1 axis.
    Kim CH
    Immunol Cell Biol; 2009 Oct; 87(7):502-4. PubMed ID: 19652661
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury.
    Perry HM; Huang L; Ye H; Liu C; Sung SJ; Lynch KR; Rosin DL; Bajwa A; Okusa MD
    J Am Soc Nephrol; 2016 Nov; 27(11):3383-3393. PubMed ID: 26961351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.
    Kim M; Kim M; Kim N; D'Agati VD; Emala CW; Lee HT
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1827-35. PubMed ID: 17898040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog.
    Yonesu K; Kawase Y; Inoue T; Takagi N; Tsuchida J; Takuwa Y; Kumakura S; Nara F
    Biochem Pharmacol; 2009 Mar; 77(6):1011-20. PubMed ID: 19150609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung T lymphocyte trafficking and activation during ischemic acute kidney injury.
    Lie ML; White LE; Santora RJ; Park JM; Rabb H; Hassoun HT
    J Immunol; 2012 Sep; 189(6):2843-51. PubMed ID: 22888136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury.
    Bajwa A; Huang L; Kurmaeva E; Gigliotti JC; Ye H; Miller J; Rosin DL; Lobo PI; Okusa MD
    J Am Soc Nephrol; 2016 Apr; 27(4):1076-90. PubMed ID: 26286732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P.
    Kohno T; Igarashi Y
    Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by Xia regarding article, "High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor".
    Xia P
    Circulation; 2007 Apr; 115(14):e393; author reply e394. PubMed ID: 17420358
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the T-cell receptor in kidney ischemia-reperfusion injury.
    Savransky V; Molls RR; Burne-Taney M; Chien CC; Racusen L; Rabb H
    Kidney Int; 2006 Jan; 69(2):233-8. PubMed ID: 16408111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1 phosphate: a new player in osteoimmunology.
    Boyce BF
    Dev Cell; 2009 Mar; 16(3):323-4. PubMed ID: 19289077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
    Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Death and taxis: what non-mammalian models tell us about sphingosine-1-phosphate.
    Oskouian B; Saba JD
    Semin Cell Dev Biol; 2004 Oct; 15(5):529-40. PubMed ID: 15271298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.